About Us
Our Mission
We are a fast-growing startup founded in 2013. Our mission is to enable everyone to be actively involved in their well-being and health through products that are simple and pleasant to use.
Our flagship product, K'Watch Glucose, is a Continuous Blood Glucose Monitor (CGM) which takes the form of a smartwatch and is accompanied by a patch that makes the CGM invisible and painless.
The development of our product has been supported from the outset by public (Ile-De-France Region, BPI France, Eurostars, EIC accelerator) and private funding (specialised Business Angels and Beurer, a German leader in diabetes).
Our values
Nothing is impossible
We seek to push the limits in every domain, to find innovative and unexpected solutions. We are shifting the boundaries of the possible for the ultimate well-being of those who will use our products.
Passion and Faith
We are driven by a common passion: to create products and services that are both simple and pleasant to use. We believe in their immense potential for human beings.
Active Listening
Listening and caring are at the core of our approach. Everyone’s experience and opinion is unique. We treasure this, and strive to find it in every interaction.
Our history…
Won the 12th edition of the Healthcare Innovation World Cup
November 2020
Laureate of the EIC Accelerator program
September 2020 - Highly selective program (2,7% success rate)
Start of the research on multi-analyte monitoring
September 2020 - Funded by the Eurostars and Innov'up Leader PIA programs
Seed fundraising tour closed with a total of €3,4m
June 2020
Key partnership with Beurer GmbH
January 2020 - A major distributor of blood monitors in Germany, Italy and Austria
Won the EIT Health European Catapult award
December 2019 - In Medtech category, a contest gathering more than 200 of the best european health startups.
Co-accelerated by Dassault Systèmes and Sanofi
November 2019 - 1st company to be co-accelerated by the two giants
Creation of Advisory Board
June 2019 - With John Brooks, co-founder of Insulet and ex CEO of the Justin Diabetes Center, and Alexandre Richard, M&A director Sanofi
K’Watch announced as a Continuous Glucose Monitoring device
December 2018
Successful results of in vivo tests
November 2018
Seal of Excellence of the H2020 Phase 2
May 2018 - Delivered by the European Commission
Laureate of the Concours d’Innovation Numérique
December 2017 - Organized by BPIfrance
Successful crowdfunding equity campaign
August 2017
Participation at the CES Las Vegas
January 2017 - 3 awards including the prestigious BEST OF INNOVATION
Project initiated
January 2016
PK, pronounced “Pekka” in French, means star in Polynesian dialect
It’s the encounter of the tribal world, our origins, and the stars, a journey, an adventure.
This is PK, a journey towards the human being.
Our team
Let’s keep in touch
Be notified of the progress of K'Watch by subscribing to the newsletter*.
* Your e-mail and IP address shall be collected to send you our newsletter and targeted information about the activities of PKvitality.